Chemoinformaics analysis of OCTANOIC-ACID-METHYL-ESTER
| Molecular Weight | 144.214 | nRot | 6 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 1 |
| Exact Molecular Weight | 144.115 | nRing | 0 |
| Solubility: LogS | -2.334 | nHRing | 0 |
| Solubility: LogP | 2.85 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 25.6327 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.581 |
| Synth | 1.483 |
| Natural Product Likeliness | 0.694 |
| NR-PPAR-gamma | 0.865 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.782 |
| MDCK | 0.0000297 |
| BBB | 0.87 |
| PPB | 0.891833 |
| VDSS | 0.247 |
| FU | 0.141753 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.541 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.651 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.965 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.04 |
| CL | 3.966 |
| T12 | 0.799 |
| hERG | 0.015 |
| Ames | 0.007 |
| ROA | 0.108 |
| SkinSen | 0.279 |
| Carcinogencity | 0.193 |
| EI | 0.99 |
| Respiratory | 0.25 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.945148 |